"The Indian Health Ministry said in a statement that tests samples of Coldrif cough syrup, made by Sresan Pharma in Tamil Nadu, contained diethylene glycol (DEG). DEG is an industrial solvent and is highly toxic if ingested even in small amounts. "The samples are found to contain DEG beyond the permissible limit," the ministry statement said. "The sale of this syrup has been banned throughout Madhya Pradesh," said Mohan Yadav, the chief minister of the central Indian state, where most of the deaths occurred."
"The incident has renewed scrutiny of India's pharmaceutical industry. In 2022, the World Health Organization (WHO) linked cough syrups made by another Indian company to the deaths of 70 children in The Gambia. New Delhi had disputed the WHO findings. A year later, the WHO again warned against two cough medicines made in India after Uzbekistan linked the syrup to the deaths of at least 18 children. A fifth global warning against India-made medication in a 10-month span was issued after medicines contaminated with toxins were found in Iraq."
Test samples of Coldrif cough syrup contained diethylene glycol (DEG), a highly toxic industrial solvent, and at least nine children died after allegedly consuming the syrup. The product was manufactured by Sresan Pharma in Tamil Nadu. Madhya Pradesh banned the syrup and other Sresan Pharma products; Tamil Nadu and Kerala also banned sales, and Telangana issued a public alert. The incident intensified scrutiny of India's pharmaceutical industry after previous WHO-linked warnings about contaminated cough syrups tied to child deaths in The Gambia and Uzbekistan and toxin-contaminated medicines found in Iraq. India supplies roughly 20% of global generic medicines.
Read at www.dw.com
Unable to calculate read time
Collection
[
|
...
]